Two days after receiving an 0.18-mg intravitreal fluocinolone acetonide implant (Yutiq; EyePoint Pharmaceuticals) in his left eye, a 30-year-old man returned to the clinic. He denied pain or visual changes. On examination, the implant was visible in the anterior chamber (Figure), with no corneal edema, hyphema, or intraocular pressure elevation. The patient had a history of a ruptured globe with a resulting iris defect, retinal detachment after a vitrectomy, a posterior capsular tear, anterior chamber inflammation, and chronic cystoid macular edema. His baseline visual acuity (20/70 OS) improved to 20/40 OS with intravitreal steroid injections but worsened to 20/70 OS when the cystoid macular edema recurred after injections were ceased. Because the patient had declined surgery or recurrent injections, he had consented to and received the implant after a careful discussion of risks, including migration into the anterior chamber,1 as indicated in the product description for those without intact posterior capsules. Immediately after surgery to remove the implant, his cornea was clear and his visual acuity was 20/70 OS.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Li AS, Nguyen HV, Do DV. Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber. JAMA Ophthalmol. 2020;138(10):e201388. doi:10.1001/jamaophthalmol.2020.1388
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: